382 related articles for article (PubMed ID: 16417699)
1. Trisomy 18 fetuses with cystic hygroma linked to positive maternal serum Down's syndrome Triple test screening result.
Celentano C; Guanciali-Franchi PE; Liberati M; Prefumo F; Palka G; Rotmensch S
J Med Screen; 2005; 12(4):203. PubMed ID: 16417699
[No Abstract] [Full Text] [Related]
2. Prenatal screening using maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol: two-year experience in a health maintenance organization.
McDuffie RS; Haverkamp AD; Stark CF; Haverkamp C; Barth CK
J Matern Fetal Med; 1996; 5(2):70-3. PubMed ID: 8796771
[TBL] [Abstract][Full Text] [Related]
3. Multiple marker screening test: identification of fetal cystic hygroma, hydrops, and sex chromosome aneuploidy.
Wenstrom KD; Boots LR; Cosper PC
J Matern Fetal Med; 1996; 5(1):31-5. PubMed ID: 8796763
[TBL] [Abstract][Full Text] [Related]
4. Triploidy identified through second-trimester serum screening.
Huang T; Alberman E; Wald N; Summers AM
Prenat Diagn; 2005 Mar; 25(3):229-33. PubMed ID: 15791661
[TBL] [Abstract][Full Text] [Related]
5. Cystic hygroma and mid-trimester maternal serum screening.
Celentano C; Prefumo F; Iezzi I; Guanciali-Franchi PE; Palka C; Liberati M; Rotmensch S
J Med Screen; 2007; 14(3):109-12. PubMed ID: 17925081
[TBL] [Abstract][Full Text] [Related]
6. Making sense of maternal serum screening.
Lindsay P
Nurs Times; 1994 Dec 7-14; 90(49):30-2. PubMed ID: 7528377
[TBL] [Abstract][Full Text] [Related]
7. The role of maternal serum alpha-fetoprotein, human chorionic gonadotrophin and oestriol in the antenatal screening of Down's syndrome.
Chang TC; Cheng HH
Med J Malaysia; 1994 Dec; 49(4):351-4. PubMed ID: 7545778
[TBL] [Abstract][Full Text] [Related]
8. Maternal serum markers for Down's syndrome pregnancies.
Chew S; Anandakumar C; Ratnam SS
Singapore Med J; 1995 Aug; 36(4):417-23. PubMed ID: 8919160
[TBL] [Abstract][Full Text] [Related]
9. First- and second-trimester screening: detection of aneuploidies other than Down syndrome.
Breathnach FM; Malone FD; Lambert-Messerlian G; Cuckle HS; Porter TF; Nyberg DA; Comstock CH; Saade GR; Berkowitz RL; Klugman S; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; Tripp T; Bianchi DW; D'Alton ME;
Obstet Gynecol; 2007 Sep; 110(3):651-7. PubMed ID: 17766613
[TBL] [Abstract][Full Text] [Related]
10. Pregnancy outcomes of women with positive serum screening results for Down syndrome and trisomy 18.
Summers AM; Huang T; Wyatt PR
Prenat Diagn; 2002 Mar; 22(3):269-71. PubMed ID: 11920909
[No Abstract] [Full Text] [Related]
11. Maternal serum screening of Palestinian women in the West Bank.
Husseini A; Akkawi M
East Mediterr Health J; 2005 Jul; 11(4):824-7. PubMed ID: 16700399
[TBL] [Abstract][Full Text] [Related]
12. [The prenatal diagnosis of Down's syndrome based on the biochemical screening of maternal serum markers].
Arbuzova SB; Nikolenko MI; Khlevnaia LA; Fedotova OO; Solov'eva VD; Malova SA
Tsitol Genet; 1998; 32(1):66-71. PubMed ID: 9695254
[TBL] [Abstract][Full Text] [Related]
13. [Trisomy-21 screening using AFPplus in the eastern part of Switzerland].
Zimmermann R; Schmid W; Binkert F; Achermann J; Huch R; Huch A
Schweiz Med Wochenschr; 1995 Jul; 125(26):1286-93. PubMed ID: 7541552
[TBL] [Abstract][Full Text] [Related]
14. Maternal serum screening in Ontario using the triple marker test.
Summers AM; Farrell SA; Huang T; Meier C; Wyatt PR
J Med Screen; 2003; 10(3):107-11. PubMed ID: 14561260
[TBL] [Abstract][Full Text] [Related]
15. Experience on triple markers serum screening for Down's syndrome fetus in Hat Yai, Regional Hospital.
Lamlertkittikul S; Chandeying V
J Med Assoc Thai; 2007 Oct; 90(10):1970-6. PubMed ID: 18041410
[TBL] [Abstract][Full Text] [Related]
16. Human chorionic gonadotrophin and trisomy 18.
Barkai G; Chaki R; Sochat M; Goldman B
Am J Med Genet; 1991 Oct; 41(1):52-3. PubMed ID: 1719814
[TBL] [Abstract][Full Text] [Related]
17. The sensitivity of the trivariate analysis using maternal serum alpha-feto protein, human chorionic gonadotrophin and maternal age in screening for fetal aneuploidy in mothers above the age of 35.
Anandakumar C; Chew S; Wong YC; Goh VH; Tain CF; Ratnam SS
J Perinat Med; 1999; 27(3):178-82. PubMed ID: 10503178
[TBL] [Abstract][Full Text] [Related]
18. Maternal serum-integrated screening for trisomy 18 using both first- and second-trimester markers.
Palomaki GE; Neveux LM; Knight GJ; Haddow JE
Prenat Diagn; 2003 Mar; 23(3):243-7. PubMed ID: 12627428
[TBL] [Abstract][Full Text] [Related]
19. [Screening for Down syndrome using triple marker testing in the second trimester of pregnancy].
Lesin J; Skrablin S; Durić K; Suchanek E; Muzinić D; Kalafatić D; Kuvacić I; Zlopasa G; Plavec A
Lijec Vjesn; 2003; 125(3-4):55-60. PubMed ID: 12899094
[TBL] [Abstract][Full Text] [Related]
20. Maternal serum screening for Down's syndrome, open neural tube defects and trisomy 18.
Akbas SH; Ozben T; Alper O; Ugur A; Yücel G; Lüleci G
Clin Chem Lab Med; 2001 Jun; 39(6):487-90. PubMed ID: 11506458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
